Spasticity

1
Spasticity

Spasticity is a neurological condition characterized by increased muscle tone and uncoordinated movements. The condition results from damage to the upper motor neurons, resulting in inappropriate muscle tension even in the absence of voluntary movement. Spasticity may accompany a variety of neurological disorders, including strokes, spinal cord injuries, cerebral palsy, and other central nervous system injuries. Clinically, it manifests as muscle stiffness, limited joint mobility, and rigidity. Spasticity can range from mild muscle tension to deep, uniform spasms that affect patients' quality of life.

History of the disease and interesting historical facts

The history of spasticity research goes back to ancient times. The first descriptions of a condition similar to spasticity are reported in the works of Hippocrates and Galen, where they mention increased muscle tone after injuries or lesions of the nervous system. In the 19th century, disorders associated with muscle hypertonicity began to be studied more systematically. One of the first to substantiate the connection between damage to upper motor neurons and spasticity was the French neurologist Jean-Martin Charcot. In the 20th century, with the development of neurophysiology and neurorehabilitation, it became possible to develop effective treatment methods using physiotherapy and pharmacotherapy, which made it possible to significantly improve the quality of life of patients.

Epidemiology (statistics of disease occurrence)

The epidemiology of spasticity varies depending on the population and the underlying disease causing the condition. According to statistics, spasticity is observed in 35-56% patients who have had a stroke and in 80% children with cerebral palsy. Overall, the prevalence of spasticity worldwide is about 1-2%. In people who have had spinal cord injuries, the rate of spasticity can reach 90%. It is also noted that women suffer from spasticity slightly more often than men, which may be due to differences in the neurological system and predisposition to injury.

Genetic predisposition to this disease

The genetic aspects of spasticity are not well understood, but some studies have implicated certain genes and mutations in its development. For example, mutations in genes involved in nervous system function can lead to disruption of motor neuron signaling. Genes such as SPAST and ATL1 have been linked to hereditary spasticity, particularly in cases of spinal muscular atrophy. It is important to note that hereditary predisposition to spasticity can be complex and depend on the interaction of multiple genes and environmental factors.

Risk factors for the development of this disease

Various factors can contribute to the development of spasticity, including:

  • Physical factors: circulatory disorders, injuries, strokes;
  • Chemical factors: toxic effects, intoxication;
  • Other factors: central nervous system infections, metabolic disorders, birth injuries.

These factors in combination may increase the predisposition to spasticity, especially in people with pre-existing neurological disorders.

Diagnosis of this disease

Diagnosis of spasticity involves several steps, starting with a clinical examination and anamnesis analysis. The main symptoms of spasticity include:

  • Symptoms of muscle stiffness and spasm;
  • Limited joint mobility;
  • Unstable equilibrium.

Laboratory tests may include a complete blood count and biochemical tests to rule out metabolic and infectious diseases. It is also important to perform radiological examinations, such as MRI or CT, to detect damage to the structures of the central nervous system. A successful diagnosis requires differential analysis with other neurological diseases, such as myositis or muscular dystrophies.

Treatment

Treatment of spasticity is complex and may include:

  • General treatment: physiotherapy, movement training and mechanotherapy;
  • Pharmacological treatment: muscle relaxants, anticonvulsants;
  • Surgical treatment: spinal cord surgery, anatomical reformation;
  • Other types of treatment: Botulinum therapy, acupressure, alternative methods.

Treatment is selected individually, the main goal of which is to reduce spasticity and improve the patient's functional capabilities.

List of medications used to treat this disease

Some of the most commonly used medications to treat spasticity include:

  • Dantrolene;
  • Tizanidine;
  • Baclofen;
  • Promedol;
  • Botulinum toxin type A.

These drugs are aimed at reducing muscle tone and improving mobility.

Disease monitoring

Spasticity monitoring involves monitoring the patient's condition and the effectiveness of therapy. The main control stages include:

  • Regular medical check-ups;
  • Assessment of the level of spasticity using scales and questionnaires;
  • Planning subsequent therapeutic interventions.

The prognosis for spasticity varies depending on the underlying disease and the extent of the disorder. Potential complications include muscle contractures, atrophy, and chronic pain.

Age-related features of the disease

Spasticity can manifest itself in different age groups and has its own characteristics depending on age:

  • In newborns: Causes may include hypoxia and birth trauma, treatment begins at an early age;
  • In children: often associated with cerebral palsy, treatment includes intensive rehabilitation;
  • In adults: The causes are most often associated with stroke and trauma, accompanied by a high level of disability.

An age-appropriate approach to treating spasticity can significantly impact the effectiveness of rehabilitation.

Questions and Answers

  • What is spasticity? Spasticity is a condition characterized by increased muscle tone due to damage to the upper motor neurons. It manifests itself as muscle stiffness and limited joint mobility.
  • What factors can cause spasticity? Major risk factors include trauma, stroke, central nervous system infections and metabolic disorders.
  • How is spasticity diagnosed? Diagnosis is based on clinical examination, laboratory tests, radiological examinations and differential analysis with other diseases.
  • How is spasticity treated? Treatment includes drug therapy, physical therapy, botulinum therapy and, in some cases, surgery.
  • What is the prognosis for treating spasticity? The prognosis depends on the underlying disease and the severity of spasticity, but many patients can achieve significant improvement with proper therapy.

One thought on “Спастичность

  1. Cinthia Rodriguez arias says:

    A mi hija le dio un infarto de médula espinal ahora tiene mucha espastidad músculos duros camina arrastrando un piecito eso le dio a los 26 años ahora tiene 50 años me gustaría que me la ayudarán somos personas de escasos recursos economicos

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.